Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tc 99m ethylenedicysteine deoxyglucose - CellPoint

Drug Profile

Tc 99m ethylenedicysteine deoxyglucose - CellPoint

Alternative Names: (99m)Tc ethylenedicysteine-deoxyglucose; 99m-Tc-EC-DG; 99mTC ethylene dicysteine deoxyglucose; 99mTc ethylenedicysteine N-acetyl glucosamine; 99mTc-oncardia; EC-deoxyglucose-Tc-99m; Ethylenedicysteine-deoxyglucose-Tc-99m; Oncardia-Tc-99m; Oncardia®; Tc 99m EC glucosamine; Tc 99m ethylenedicysteine glucosamine; Tc-99m-Oncardia; Technetium TC 99m ECDG; Technetium-99m-labeled Ethylenedicysteine-Deoxyglucose; Technetium-99m-labeled ethylenedicysteine-glucosamine; Technetium-99m-labelled-Oncardia

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CellPoint LLC
  • Developer CellPoint; University of Chicago
  • Class Diagnostic conjugates; Organotechnetium compounds; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Technetium compounds
  • Mechanism of Action Ionising radiation emitters; Single-photon emission-computed tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes - Lung cancer; Myocardial ischaemia

Highest Development Phases

  • Phase III Lung cancer
  • Phase II Myocardial ischaemia; Non-small cell lung cancer
  • No development reported Head and neck cancer

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for phase-I development in Head-and-neck-cancer(Diagnosis) in USA (IV, Injection)
  • 03 Aug 2015 No recent reports on development identified - Phase-II for Non-small cell lung cancer (Diagnosis) in Canada (IV)
  • 01 Feb 2015 Tc 99m ethylenedicysteine deoxyglucose is still in phase II trials for Myocardial ischaemia (Diagnosis) in USA
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top